This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
By This Author:
Page 3 of 783

Kythera CEO Sees Big Profits in Double Chins

By Gregg Greenberg

Allergan blazed a trail when its wrinkle-fighting treatment Botox opened up the facial aesthetics market. Now Kythera is attempting to follow that path with its double-chin drug Kybella.

12:03PM 05/19/15

Double Chin Drug Kybella Following Botox Lead Says Kythera CEO

By Gregg Greenberg

Kythera has high expectations for the targeted launch of its FDA-approved double chin injection Kybella in the second half of 2015, said the company's CEO Keith Leonard.

11:39AM 05/19/15

Medifast CEO Sees a Strong Second Half

By Gregg Greenberg

Bathing-suit season is fast approaching and Medifast CEO Michael MacDonald says his weight-loss company is ready to impress the gawkers on Wall Street.

05:22PM 05/18/15

Second Half Looks Strong Despite Higher Ad Spending Says Medifast CEO

By Gregg Greenberg

Medifast finished the first quarter ahead of where it wanted to be and the weight loss company is now gearing up for a strong second half, says CEO Michael MacDonald.

04:29PM 05/18/15

Rare Disease Drug Demand, Soros Interest Raising PlasmaTech Profile

By Gregg Greenberg

PlasmaTech Biopharmaceuticals is enjoying a higher profile now that the business community is paying more attention to rare disease treatments, said the company's CEO Tim Miller.

04:26PM 05/18/15

Why You Are Doing 'Shadow Work' for Free and Don't Even Know It

By Gregg Greenberg

‘Shadow Work’ includes all the unpaid tasks we do on behalf of businesses and organizations every day from pumping gas to bagging groceries, said Craig Lambert, author of 'Shadow Work.'

06:00AM 05/16/15

IMAX, Six Flags Pricey But Worth the Trip Says William Blair Manager

By Gregg Greenberg

IMAX's international expansion and new laser technology will continue to drive the company's stock higher, said Michael Balkin, Portfolio Manager for the William Blair Small Cap Fund.

04:44PM 05/15/15

Regulations Seriously Stifling Banks Says 'Wall Street Wars' Author

By Gregg Greenberg

Historically speaking Wall Street banks are indeed being stifled by burdensome regulations in the aftermath of the 2008 crash, but the kinks will eventually be worked out.

03:55PM 05/15/15

Elon Musk Is on His Way but He's No Steve Jobs Just Yet

By Gregg Greenberg

Elon Musk may be a brilliant and intense businessman, but don't put him next to Thomas Edison or Steve Jobs just yet, says Ashlee Vance, author of 'Elon Musk.'

01:34PM 05/15/15

Why Setting 'Simple Rules' Can Make You a Better Investor

By Gregg Greenberg

Establishing simple guidelines or rules takes the emotion out of investing and that loss of emotional control is a big reason why people lose money in the market.

12:32PM 05/15/15

Page 3 of 783

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV


DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs